about
A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunitiesAnti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up studyHigh-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseasesIncidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study.Growing up with chronic arthritis: the confusing matter of classificationJuvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting.Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD.Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort.Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort.Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter.Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome.The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO studyOngoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritisChorea in juvenile primary antiphospholipid syndrome. Reversible decreased circulation in the basal ganglia visualised by single photon emission computed tomography[Kingella kingae and osteoarticular infections in children]Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based settingBiomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodiesDifficulties in defining antinuclear antibody-positive patients as a separate category in the classification of juvenile idiopathic arthritis: comment on the article by Ravelli et alHLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritisEarly Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort StudyStandardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based RecommendationsParticipation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
P50
Q33576975-FC584B6E-3DF3-4264-80F4-997D06049FB6Q33770863-BE68142E-E5FE-413F-8D63-8D076DC8CF1FQ37658174-7FED081A-610D-45DC-81AC-E7FB5FD1536EQ38913955-B225664A-0AFC-4E8B-98B0-AB01758FB6E9Q39080731-F009FD74-0FD8-4A0D-B22B-1C7D27D97F3AQ40078094-9EEC7F2B-FD00-4D70-BE36-F4EEB4B60698Q40693972-D19903B7-633E-4149-9133-3505C4246FA4Q40709078-84D778F5-53DE-418E-A47C-0DA756D997A7Q42333410-8C220720-F9BF-498E-A4A6-06B13797A758Q45813268-6C904833-E488-4FC6-A4B6-0D24343A2BD0Q46231014-A8F67563-ECE8-42AA-8238-365905FBF38AQ46381362-D92A3F3B-CF30-4062-8C9C-65913790097CQ46381974-C9E9FCE9-9CBF-44A7-A5CB-FBCEB8F83A0EQ47268739-66780650-41C4-404D-A388-23F6D03FEAA2Q47668191-CFCFA4A9-9CBE-49C4-8E32-8EA0BDA0C1D5Q50095442-26E28F61-EC81-4611-82B1-448F3C600B3FQ51158792-7E40C224-60B6-4ABC-A688-6480AC3AB563Q52594885-D6461BFF-13A4-4481-B06A-892903477BE8Q55023560-FAEDF595-C51A-45F7-91D9-537F7BE0B1C7Q56966414-13C92579-43F2-4707-A1B3-8D8DCB4BF1AEQ58069239-FFF942D9-EBB0-4D12-ADF0-369790EA4A5AQ73197908-BF3FB102-30D8-4077-9D52-F3D578A86C3DQ76381738-0595A8ED-47F8-4060-8AE3-582C63533930Q83278139-ED4E0DD8-67D3-400D-A998-1AC856779733Q84148279-77938413-A7AC-444D-B82D-1BB08E649DE8Q84905807-5476054C-6B0C-431E-80D0-D8784A3901E6Q86520162-C4CDCC1A-5AD7-4DC1-9261-F6E1F73BB571Q90585226-B37C4D09-8381-4D8F-B8A3-7759A0B2D227Q91062283-E5619CFC-B97C-427D-876D-ADFCF26496E1Q91895302-8AB3B78A-EFE3-4429-9B86-83F797A57CE9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ellen Berit Nordal
@ast
Ellen Berit Nordal
@en
Ellen Berit Nordal
@es
Ellen Berit Nordal
@nl
type
label
Ellen Berit Nordal
@ast
Ellen Berit Nordal
@en
Ellen Berit Nordal
@es
Ellen Berit Nordal
@nl
prefLabel
Ellen Berit Nordal
@ast
Ellen Berit Nordal
@en
Ellen Berit Nordal
@es
Ellen Berit Nordal
@nl
P106
P21
P31
P496
0000-0001-5041-3928